SORT BY Relevancy
Allison Risha, RN, BSN, OCN, a nursing program coordinator from the Levine Cancer Institute in Charlotte, North Carolina, joins Mike and Joyce to talk about the current state of clinical trials for genitourinary cancers. Ms. Risha has worked in many aspects of cancer treatment, and is currently a planner and organizer of programs for staff members and patients. Please join us, and bring your own questions about clinical trials, what they offer beyond standard treatments, and what to think abo
In 2013 Pfizer launched the Pfizer Blue Button Project, a first-of-it’s-kind initiative enabling patients who have participated in clinical trials the opportunity to download their individual clinical data. Using the Blue Button standard launched by the White House, patients will be empowered to use the data to improve their overall health and wellness, from sharing with healthcare providers to powering clinical risk assessments. In this show, our host Craig Lipset,
How a patient experiences a clinical trial is changing. Access, ease, efficiencey, safety and better quality data collection are the target goals. This episode features some of the emerging technologies together with a discussion on the opportunities and challenges to include patient access, recruitment and retention. Predictions for 2014 are shared by our guests. Host: Craig H. Lipset, MBA Head of Clinical Innovation, Worldwide Research and Development, Pfizer Inc. Guests: Tomasz Sabl
Our guest on Monday, February 10, 2014 is David Fuehrer. Dave is a two-time testicular cancer survivor and President of CureLauncher, a company he cofounded. Prior to doing so, Dave spent 10 years developing new products across North America, China and Europe for Pfizer, General Electric, Dow and many others. Dave will share his mission to solve the clinical trial enrollment problem that currently exists in the United States. His company and website connects people to lifesaving med
Join guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication and service? Hosted by Valerie Bowling, Executive Director, the Conference Forum, this episode addresses one of the hottest topics at the Patients as Partners event scheduled for March 3-4, 2014 in Philadelphia. For more information, visit www.theco
This episode provides a recap on what's happening with mobile/sensors in clinical trials especially as they affect patients. Host: Craig Lipset, Head of Clinical Innovation, R&D, Pfizer, Inc. Guests: Tim Davis, CEO & Co-Founder, Exco InTouch Abbe Steel, Vice President of Patient & Physician Services, UBC
Topic: Plastic Surgeon Reports on his Clinical Results with ML830 Cold Laser Guest: Dr. Man, MD Host: Mike Barbour Take a 90 Day Test Drive: www.ml830wholesale.com Prices starting under $3000 1-888-658-3094, ext 101
in Self Help
WHOLISM...the act and condition of being whole, complete,Authentic! How do we maintain our health and sanity when serious prognoses invade our sense of comfort and security?
How does Cancer develop and what are the conditions of its Opportunist invasions?uch
Can food be of any consequence to such dire circumstances?
Doctors want us to avoid giving our bodies Nutritional advantages when in their care...they say they will "interfere" with the medical model...is that valid? Is it more likely that we further challenge the body's ability to rally and heal if we drain it of its own resources and functions?
How much do Allopathic drugs and proceedures destroy of the body...and of the pathogen?
Can food have ANY bearing on all this?
These are questions Michael Pellegrino, Clinical Nutritionist will again answer as best he can.
Michael's passion is to become fully knowledgeable about cancer and how nutrition plays its part in a cancer's survival or clearing.
With Great Love,
Rev. Irene Windhorse
Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig is Jeff Lee, CEO, Omniscience to discuss featured news and trends in clinical trial innovation an
Dr. Robert Z. Orlowski is back on Cure Panel this March.
Robert Z. Orlowski, MD, PhD, is Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. He is board-certified in internal medicine and medical oncology. Dr. Orlowski earned his doctoral degree in molecular biophysics and biochemistry from Yale University and his medical degree from the Yale University School of Medicine. He completed his internship and residency in Internal Medicine at Barnes Hospital at the Washington University in St. Louis School of Medicine. Dr. Orlowski has published numerous book chapters, articles, and abstracts on cancer therapy, with a focus on the molecular pathogenesis of oncologic disease processes and the mechanisms of action of chemotherapeutics.
The show will be co-hosted by Gary Petersen and on the panel are Pat Killingsworth, Jack Aiello, and Cynthia Chmielewski.
REGISTER here: http://curepanel.carefeed.net/event/rsvp/20/ (or)
I am having a Very unique converstation with Dr. Charlene Brannon about a Very unique subject, the "aging odor". Dr. Brannon has found a solution for a not so pleasant challenge as we age.
Mirai Clinical is introducing recent Japanese personal hygiene advances to the American market. It is common knowledge that an unpleasant odor is frequently noticed in nursing homes. This odor, sometimes referred to as "aging odor" or “old people smell”, has been incorrectly attributed to improper facilities cleaning, or incontinence and other ailments of the patients. The problem is particularly irksome in Japan, which has a culture of cleanliness as well as disproportionately ageing population.
The researchers discovered that as skin matures, its natural antioxidant protection decreases, lipid acid in sebaceous glands gets oxidized more easily, resulting in the production of Nonenal (no-nay-nal).
The minerals and water from our sweat are a fertile environment for bacterial growth, which is the source of traditional body odor noticed when we do not bathe adequately, and in locker rooms. Separately, the lipid acids we secrete "oxidize" with oxygen in the air, and transform into a different compound, which produces it's own odor. The researchers who discovered the phenomenon named the stale smelling compound "Nonenal (no-nay-nal)".
Join Host Live Chats
- YusefEL (59 chatters)
- churchfolk (25 chatters)
- WGAG Radio (17 chatters)
- AFP Radio Network (7 chatters)
- Earth Angels Radio (7 chatters)
- Jay King Network (6 chatters)
- Star Nations Radio Network (6 chatters)
- Wolf and the bear Network (6 chatters)
- BonnieAlbersOnAir (5 chatters)
- Take Time Ministries (3 chatters)
- TalkSouthRadio (2 chatters)
- The Boochcast (1 chatters)
- hollischapmanshow (1 chatters)
- Jamelle Sanders (1 chatters)